ABSTRACT Resveratrol is a naturally occurring phytoalexine found in medicinal plants. We found that resveratrol, at doses of 2.5 and 10 mg/kg, significantly reduced the tumor volume (42%), tumor weight (44%) and metastasis to the lung (56%) in mice bearing highly metastatic Lewis lung carcinoma (LLC) tumors, but not at a dose of 0.6 mg/kg. Resveratrol did not affect the number of CD4 ϩ , CD8
Resveratrol (3,4Ј,5-trihydroxystilbene) is a naturally occurring polyphenolic phytoalexine found in medicinal plants of the Polygonum species (Polygonaceae). In a previous report, we showed that resveratrol reduced lipogenesis from palmitate in the liver and adipose tissue in vivo (1) . Furthermore, we reported that resveratrol strongly inhibited the formation of 5-lipoxygenase products, 5-hydroxy-6,8,11,14-eicosatetraenoic acid, leukotrienes B 4 and C 4 , and the cyclooxygenase product thromboxane B 2 from arachidonic acid (2) (3) (4) . We also showed the inhibitory effect of resveratrol on arachidonic acid-induced platelet aggregation (2) . Resveratrol and its derivatives have been further shown to strongly inhibit the degranulation of human polymorphonuclear leukocytes (4) . Recently, there have been a number of reports that resveratrol inhibits tumor growth and causes apoptosis as a cancer chemopreventive mechanism (5) (6) (7) (8) (9) (10) (11) (12) . Tumor angiogenesis involves the directional sprouting of new vessels toward a solid tumor. It should be noted that angiogenesis is no less important to the growth of secondary tumor colonies than it is to the growth of primary solid tumors. Secondary tumors often give rise to ternary tumors in distant organs by a process termed metastatic cascade (13) (14) (15) (16) . Previously, we reported that piceid (resveratrol-3-O-D-glucoside) inhibited the lung metastasis and the capillary-like network formation induced by Matrigel from human umbilical vein endothelial cells (HUVEC) 2 (17) , and it has been suggested that piceid administered orally may be converted to an aglycone form of resveratrol by hydrolysis (17) . The inhibition of distant metastasis to lung or liver from primary solid-tumors by resveratrol is as yet unproven. In the present study, we examined the effects of resveratrol isolated from Polygonum cuspidatum root on tumor growth and lung metastasis in mice bearing highly metastatic 1 To whom correspondence should be addressed. E-mail: yokim@m.ehime-u.ac.jp. 2 Abbreviations used: BAEC, bovine aorta endothelial cell; BCECF, 3Ј-Oacetyl-2Ј,7Ј-bis(carbocyethyl)-4 or 5-carboxylfluorescein; DMEM, Dulbecco's modified Eagle's medium; EBM, endothelial basal medium; EGM, endothelial basal medium supplemented growth factor; FBS, fetal bovine serum; FITC, fluorescein isothiocyanate; HUVEC, human umbilical vein endothelial cells; IC 50 , 50% inhibitory concentration; LLC, Lewis lung carcinoma; NK, natural killer; NMR, nuclear magnetic resonance; PE, phycoerythrin; TCA, trichloroacetic acid; VEGF, vascular endothelial growth factor. Lewis lung carcinoma (LLC) tumors, and angiogenesis in tumor-induced in vivo and in vitro models.
MATERIALS AND METHODS
General experimental procedure. Melting points, determined using a Yamato MO-21 capillary apparatus (Yamato Science, Tokyo, Japan), are uncorrected. Infrared and UV spectra were measured using a Shimadzu IR-400 spectrometer (Shimadzu, Kyoto, Japan) and a JASCO ORD/UV-5 spectrometer (JASCO, Tokyo, Japan), respectively. The 1 H nuclear magnetic resonance (NMR) (4899.83 Hz) spectrum was recorded in DMSO-d 6 and solvent plus D 2 O using a Varian Unity Inova 500 spectrometer (TOSO, Tokyo, Japan). Column chromatography was performed using silica gel 60 (70 -230 mesh, ASTM, Merck KGaA, Darmstadt, Germany) and polyamide (ICN Pharmaceuticals, Costa Mesa, CA).
Materials. Stilbene such as resveratrol (3,5,4Ј-trihydroxystilbene) and piceid (resveratrol-3-O-D-glucoside) were isolated from the roots of P. cuspidatum by the method described previously (18, 19) . Briefly, the dried crushed roots (1 kg) were extracted with methanol (3 L) three times under reflux, and the extract solution was removed by reduced pressure to give dark brown extracts (210 g). Methanol extract (200 g) was chromatographed on a silica gel column eluted with a mixture of chloroform/methanol (3:1 to 1:1, v/v) and polyamide column-eluted methanol to give resveratrol and piceid. Resveratrol and piceid were identified by direct comparison with authentic samples. Furthermore, resveratrol and piceid were identified as trans forms by the measurement of the UV and 1 H NMR spectra. Mouse lymphocyte separation medium (Lympholytes-Mouse) was purchased from Dainippon Pharmacy (Osaka, Japan). Dulbecco's modified Eagle's medium (DMEM), endothelial basal medium (EBM) and CS-C medium kits were obtained from Nissui Pharmaceutical (Tokyo, Japan), Clonetic (San Diego, CA) and Cell Systems (Kirkland, WA), respectively, and used as culture media. Antibiotic and antimycotic solutions (100 ϫ) containing 10 6 U penicillin, 10 g streptomycin and 25 mg amphotericin B/L in 9 g/L NaCl were purchased from Sigma Chemical (St Louis, MO). Fetal bovine serum (FBS) was purchased from Gibco BRL (Auckland, New Zealand). The 6-, 12-, 24-, 48-and 96-well plates were purchased from Corning Glass Works (Corning, NY). Collagen (Type I)-coated 6-and 24-well plates were purchased from Toyobo Engineering (Osaka, Japan) and Sumitomo Bakelite (Tokyo, Japan), respectively. Cells. The highly metastatic, drug-resistant mouse LLC cells were obtained from Riken Gene Bank (Tukuba, Japan) and maintained in DMEM supplemented with 100 mL/L FBS, penicillin (1 ϫ 10 5 U/L), streptomycin (100 mg/L) and amphotericin B (0.25 mg/L). HUVEC and bovine aorta endothelial cells (BAEC) were purchased from Clonetics (San Diego, CA) and Sannkou Junyaku (Tokyo, Japan), respectively; the HUVEC and BAEC were seeded onto collagen (Type I)-coated 24-or 6-well plates and maintained in Clonetics endothelial basal medium supplemented growth factor (EGM) or CS-C media.
Animals. Female C57BL/6 strain mice (5 wk old) were obtained from Clea Japan (Osaka, Japan). They were housed for 1 wk in a room maintained at 25 Ϯ 1°C with 60% relative humidity and given free access to nonpurified diet [(per 100 g diet): water 8 g, crude carbohydrate 51.3 g, crude protein 24.6 g, crude lipid 5.6 g, crude fiber 3.1 g, mineral mixture 6.4 g and vitamin mixture 1 g; Oriental Yeast, Osaka, Japan] and water. The room was illuminated for 12 h/d starting at 0700 h. Animals were treated according to the ethical guidelines of the Animal Center, School of Medicine, Ehime University.
Measurement of tumor growth and metastasis to lung in LLCbearing mice. Solid-type LLC was prepared by subcutaneous transplantation of 5 ϫ 10 5 cells (0.5 mL) into the backs of C57BL/6 female mice on d 0. Resveratrol (0.6, 2.5 or 10 mg/kg body) was administered intraperitoneally once (at 0700 h) daily for 21 consecutive days, starting 12 h after implantation of the tumor cells. Untreated mice (normal) and LLC-implanted mice (control) were given distilled water alone on the same schedule. The tumor volume was determined every 2-3 d by direct measurement with calipers and calculated using the formula, [width 2 (mm 2 ) ϫ length (mm)]/2. On d 22, the mice were killed by cervical dislocation, and the spleen, thymus and lung quickly removed and weighed. The metastases to the lung were counted using a stereoscopic microscope. The spleen tissues were gently teased to release cells by means of dissecting forceps in cold PBS (pH 7.4). The cell suspension (5 mL) was layered on Lympholytes-Mouse (5 mL) and centrifuged at 1500 ϫ g for 30 min to isolate the lymphocytes. The number of lymphocytes was measured using a Coulter Counter. The cell concentration was adjusted to 2 ϫ 10 10 cells/L, and the 10 L of FITC-labeled anti-mouse CD4, CD8 or PE-labeled antimouse NK1.1. was added to 100 L of the cell suspension. After incubation for 30 min at 4°C, the lymphocytes were rinsed three times with 1 mL of PBS and centrifuged at 700 ϫ g for 5 min. Subsequently, the CD4 ϩ , CD8 ϩ and NK1.1. ϩ T-cell populations were analyzed by flow cytometry using a FACS Calibur (Becton Dickinson, Mountain View, CA).
Measurement of DNA synthesis in LLC cells. LLC cells were placed in DMEM supplemented with 100 mL/L FBS at 1 ϫ 10 4 cell/well in 24-well culture plates. After the cells were cultured overnight, the medium was changed to fresh DMEM with 100 mL/L FBS and cells were exposed to the indicated amounts of resveratrol for 20 h; then the medium was replaced with cells/well in 6-well culture plates. After the cells were cultured overnight, the medium was changed to fresh medium and cells were exposed to the indicated amounts of resveratrol for 20 h. The detached (nonadherent) cells were collected, and the attached (adherent) cells were then dispersed by adding PBS (pH 7.4) containing 2.5 g/L trypsin and 1 mmol/L EDTA. Adherent and nonadherent cells were sedimented at 200 g for 10 min, washed with ice-cold PBS and fixed in ice-cold 700 mL/L methanol for 2 h at 4°C, and then further washed twice with ice-cold PBS. The fixed cells were incubated with 1 mL of 0.25 mg/L RNAase A for 1 h at 37°C, washed twice with PBS, stained with propidium iodide (final concentration of 50 mg/L), and subjected to apoptosis and cell cycle analysis by flow cytometry using a FACS Calibur.
Measurement of angiogenesis induced by tumor cells. In vivo angiogenesis was assayed by the dorsal air-sac method. Briefly, 3 ϫ 10 6 cultured LLC cells were suspended in DMEM and packed into a round-shaped nitrocellulose membrane chamber with a diameter of 14 mm (pore size 0.45 m; Millipore, Bedford, MA) and implanted onto the dorsal air sac of female C57BL/6 mice on d 0. Resveratrol (0.6, 2.5 or 10 mg/kg) was administered intraperitoneally twice daily from d 1 to 5. The mice were killed on d 6, and skin hair in contact with the chamber was carefully shaved. The formation of new blood vessels in the subcutaneous region was photographed.
Measurement of DNA synthesis in BAEC and HUVEC. BAEC were placed in CS-C medium containing 100 mL/L FBS at 2 ϫ 10 cells. HUVEC (1 ϫ 10 4 cells per well) were seeded onto Matrigel (10 g/well)-coated 96-well culture plates in CS-C medium containing 100 mL/L FBS. After the cells were cultured overnight, the medium was changed to fresh medium, and the cells were exposed to the indicated amounts of stilbenes for 20 h; thymidine incorporation was measured by the methods described above.
LLC cell adhesion to HUVEC. Confluent HUVEC monolayers (second passage) grown on collagen-coated 24-well culture plates were incubated with the indicated amounts of stilbenes for 6 h at 37°C in a humidified chamber containing 5% CO 2 in CS-C medium containing 100 mL/L FBS. After the incubation period, HUVEC monolayers were washed twice with CS-C medium containing 100 mL/L FBS, and then BCECF-labeled LLC cells (1 ϫ 10 4 cells per well) were seeded onto HUVEC monolayers treated with stilbenes and incubated for 2 h. After the incubation period, HUVEC were gently washed three times with the above medium to remove nonadherent LLC cells. LLC cells that adhered to HUVEC were solubilized by adding 5 g/L Triton X-100 (1 mL), and the fluorescence of BCECF released from the LLC cells was measured by fluorimetry (FP-777, JASCO) with excitation at 500 nm and emission at 540 nm. LLC cell adherence to HUVEC monolayers is expressed throughout as the percentage of adherence, and the fluorescence released from the BCECF-labeled LLC cells seeded in each well of the 24-well plates was taken as 100% total fluorescence intensity.
Measurement of tube-like network formation from HUVEC induced by Matrigel. Matrigel (150 L) was placed into each well of a 48-well culture plate at 4°C and allowed to polymerize by incubation for 1 h at 37°C. HUVEC (second passage, 2 ϫ 10 4 cells) were seeded onto the Matrigel in 270 L of DMEM supplemented with 200 mL/L FBS and incubated with the indicated amounts of resveratrol at 37°C for 24 h in a humidified 5% CO 2 atmosphere. Four different phase-contrast microscopic fields (ϫ40 and ϫ100 magnification) per well were photographed, and the photomicrograph images were stored in a computer. The total length of tube structures in each photograph (ϫ40 magnification) was measured using Adobe Photoshop software (Adobe, Tokyo, Japan).
Binding of 125 I-labeled VEGF to HUVEC. HUVEC were cultured to subconfluency on collagen-coated 24-well culture plates. The HUVEC were incubated with the indicated amounts of resveratrol for 30 min at room temperature. Subsequently, 125 I-VEGF (ϳ5.6 ϫ 10 4 dpm; specific activity 4.26 MBq/g) was added and incubated for 3 h in a humidified 5% CO 2 atmosphere. After unbound radioligand was removed, the cells were solubilized in 10 g/L SDS. The amount of 125 I-VEGF bound to HUVEC was measured using a gamma counter (COBRA II, Packard, Meriden, CT). Statistical analysis. All values are expressed as means Ϯ SEM. Data were analyzed by one-way ANOVA, and then differences among means were analyzed using Fisher's protected Least Significant Difference multiple comparison test. Differences were considered significant at P Ͻ 0.05.
RESULTS
Antitumor and antimetastatic activities. Tumor growth and final tumor weight were significantly inhibited by the intraperitoneally administered resveratrol at doses of 2.5 and 10 mg/kg, but 0.6 mg/kg of resveratrol had no effect (Fig. 1A  and B) . Resveratrol (2.5 and 10 mg/kg) significantly reduced the number of tumor cell colonies that metastasized to the lung compared with the LLC-bearing mice (Fig. 2) .
Body weight, spleen and thymus weight, and the numbers of splenic lymphocytes, CD4
؉ , CD8 ؉ and NK1.1 ؉ T cells. Resveratrol had no effect on either initial or final body weight in LLC-bearing mice compared with that in normal mice ( Table 1) . In LLC-bearing mice, the spleen weight was significantly greater than that of the normal mice. In contrast, thymus weight of LLC-bearing mice was significantly lower than that of normal mice. Resveratrol tended to prevent the increase of spleen weight and the reduction of thymus weight in LLC-bearing mice ( Table 1 ). The number of lymphocytes in the spleens of LLC-bearing mice significantly increased to 7.29 Ϯ 0.74 ϫ 10 6 from 2.90 Ϯ 0.33 ϫ 10 6 in normal mice. In contrast, the splenic CD4 ϩ and CD8 ϩ cells in LLC-bearing mice were significantly reduced to 7.69 Ϯ 0.85 and 14.1 Ϯ 1.65% from 22.5 Ϯ 0.97 and 42.9 Ϯ 3.29% in normal mice, respectively. NK1.1.
ϩ T cells were not affected. The increase in splenic lymphocyte and reductions of CD4 ϩ and CD8 ϩ T cells were not prevented by the intraperitoneally administered resveratrol (data not shown). 
DNA synthesis, apoptosis and the cell cycle in LLC cells (in vitro).
Resveratrol inhibited the DNA synthesis in LLC cells with a 50% inhibitory concentration (IC 50 ) of 6.8 mol/L (Fig. 3) . Treatment with 100 mol/L resveratrol for 24 h increased apoptosis to 20.6 Ϯ 1.35 from 12.1 Ϯ 0.36% in LLC cells ( Table 2 ). In addition, resveratrol decreased the S phase population at concentrations of 50 and 100 mol/L. The proportion of LLC cells in the G 2 /M phase of the cell cycle was increased by the treatment with 50 mol/L resveratrol.
Tumor-and Matrigel-induced angiogenesis and (in vivo and in vitro). Five days after implantation of the LLC cells, which were packed into the membrane chamber, neovascularization was evident in the region in contact with the chamber containing LLC cells. The intraperitoneally administered resveratrol (2.5 and 10 mg/kg twice per day) prevented the neovascularization induced by LLC cells (Fig. 4) . HUVEC formed capillary-like networks on Matrigel 24 h after seeding. Resveratrol dose dependently inhibited angiogenesis of HUVEC at 5-100 mol/L concentrations (Fig. 5) .
DNA synthesis in BAEC and HUVEC (in vitro). Resveratrol significantly inhibited DNA synthesis of BAEC at concentrations of 50 -500 mol/L, but not at 5 and 10 mol/L (data not shown). The inhibition ratios were 45.5% at 50 mol/L, 81.5% at 100 mol/L and 68.4% at 500 mol/L, respectively, with an IC 50 of 54 mol/L. Furthermore, resveratrol inhibited DNA synthesis of HUVEC at of 100 mol/L; its inhibition ratio was 69.3%, but not at concentrations of 5, 10 and 50 mol/L; the IC 50 was 89 mol/L (data not shown).
Adherence of LLC cells and binding of 125 I-VEGF to HUVEC (in vitro)
. When LLC cells were seeded onto the HUVEC monolayer, the adherence of LLC cells to HUVEC was increased from 10.4 Ϯ 2.8 to 50.8 Ϯ 6.4% of total cells. Resveratrol had no effect on adherence of LLC cells to HUVEC (data not shown). Resveratrol significantly inhibited the binding of VEGF to HUVEC at 10 -100 mol/L concentrations (Fig. 6) .
DISCUSSION
The removal of certain tumors, for example, breast carcinoma, colon carcinoma and osteogenic sarcoma, may be followed by the rapid growth of distant metastases to organs such as lung, liver or bone. Therefore, it is necessary to develop new anticancer agents with antitumor and antimetastatic activities. The roots of P. cuspidatum are traditionally used as a remedy or prevention for allergic inflammatory diseases, hyperlipidemia and cancer. Although resveratrol is reported to contain a cancer chemopreventive agent (5,6), the inhibitory action by resveratrol on distant metastases to other organs from primary solid-tumors is as yet unproven. In this study, we examined the effects of resveratrol contained in medicinal plants on tumor growth and metastasis to the lung using mice bearing the highly metastatic, drug-resistant mouse tumor, LLC. It has been reported that LLC-bearing C57BL/6 mice had lung metastasis in addition to tumor growth (20 -23) . We found that tumor growth and lung metastasis were inhibited by the intraperitoneal administration of resveratrol [2.5 and 10 mg/(kg ⅐ d)] for 21 consecutive days in LLC-bearing C57BL/6 mice. Mu et al. (24) and Brunda et al. (25) reported that metastases to distant organs and tumor growth were prevented through natural killer cell and cytotoxic T lymphocyte activation by the administration of interleukin-12. Because the intraperitoneal administration of resveratrol did not affect the numbers of CD4 ϩ , CD8 ϩ T cells or NK1.1 ϩ T cells in the spleens of LLC-bearing mice, the inhibitory effects of resveratrol on tumor growth and lung metastasis could not be explained by natural killer and cytotoxic T lymphocyte activation. Next, we examined the effects of resveratrol on the DNA synthesis of LLC cells. The results showed that resveratrol inhibited the DNA synthesis with an IC 50 of 6.8 mol/L. Resveratrol at 100 mol/L caused apoptosis, decreased the S phase population at 50 and 100 mol/L and increased the G 2 /M phase at 50 mol/L in LLC cells. Ragion et al. (7) reported that 30 mol/L resveratrol arrested the cell division cycle at the S/G 2 phase transition in the promyelocitic cell line HL-60. Clément et al. (11) reported that the cell death induced by 32 mol/L resveratrol in HL 60 cells is tumor specific, and reported findings supporting the involvement of the Fas-Fas ligand system as the apoptotic trigger. These findings suggest that resveratrol may contribute to the inhibition of primary tumor growth and metastasis to distant organs through the inhibition of DNA synthesis of tumor cells by resveratrol. However, the discrepancy between apoptotic and DNA synthesis inhibitory concentrations of resveratrol are unknown; therefore, further studies are warranted.
Tumor cell interactions with platelets, endothelial cells and the subendothelial matrix are considered essential intermediate steps for the completion of the metastastic cascade for tumors (14,26 -28) . To test the antimetastatic activity of resveratrol, we examined the effects of resveratrol on the interactions of LLC cells with HUVEC. Resveratrol had no effect on the adherence of LLC cells to monolayer HUVEC (data not shown), indicating that the antimetastatic activities of resveratrol are not due to inhibition of the adherence of LLC cells to HUVEC.
Angiogenesis is the growth of new capillary blood vessels from preexisting capillaries and postcapillary venules. The solid tumors cause neovascularization, and the resultant angiogenesis from solid tumors stimulates growth and metastasis (14, 15,22,29 -33) . Resveratrol inhibited tumor-induced neo- vascularization (in vivo) and capillary-like network tube formation of HUVEC (in vitro). But resveratrol also had no effect on DNA synthesis of BAEC and HUVEC at the same concentrations. Tumor cells are thought to secrete angiogenic factor(s) that induce neovascularization around the tumors (34 -36). VEGF is a secretory angiogenic factor (37). Asano et al. (38) reported that monoclonal antibody to VEGF prevented the tumor growth and tumor-induced neovascularization. Resveratrol inhibited the binding of VEGF to HUVEC at concentrations of 10 -100 mol/L. In summary, the inhibition ratios for DNA synthesis of LLC cells, capillary-like network formation DNA syntheses of BAEC and HUVEC, and VEGF binding to HUVEC by resveratrol at 10 mol/L were 65.6, 45.5, Ϫ7.1, Ϫ21.3 and 15.8%, respectively. Therefore, these findings suggest that the mechanism of antitumor and antimetastatic actions of resveratrol might be due to the inhibition of DNA synthesis in LLC cells and the inhibition of tumorinduced neovascularization through the inhibition of capillary-like network formation from HUVEC. 
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